Jason Haddock

2018

In 2018, Jason Haddock earned a total compensation of $1.8M as Chief Financial Officer at Array BioPharma, a 25% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$193,375
Option Awards$932,906
Salary$377,770
Stock Awards$305,760
Other$18,589
Total$1,828,400

Haddock received $932.9K in option awards, accounting for 51% of the total pay in 2018.

Haddock also received $193.4K in non-equity incentive plan, $377.8K in salary, $305.8K in stock awards and $18.6K in other compensation.

Rankings

In 2018, Jason Haddock's compensation ranked 6,191st out of 14,244 executives tracked by ExecPay. In other words, Haddock earned more than 56.5% of executives.

ClassificationRankingPercentile
All
6,191
out of 14,244
57th
Division
Manufacturing
2,364
out of 5,758
59th
Major group
Chemicals And Allied Products
884
out of 2,119
58th
Industry group
Drugs
740
out of 1,808
59th
Industry
Pharmaceutical Preparations
576
out of 1,382
58th
Source: SEC filing on September 14, 2018.

Haddock's colleagues

We found four more compensation records of executives who worked with Jason Haddock at Array BioPharma in 2018.

2018

Ron Squarer

Array BioPharma

Chief Executive Officer

2018

Curtis Oltmans

Array BioPharma

General Counsel

2018

Andrew Robbins

Array BioPharma

Chief Operating Officer

2018

Victor Sandor

Array BioPharma

Chief Medical Officer

News

In-depth

You may also like